Ligand Pharmaceuticals
LGND
#3601
Rank
$3.63 B
Marketcap
$184.87
Share price
-1.93%
Change (1 day)
48.10%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.52 Billion USD

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are $0.52 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.11 B29%
2023-12-31$86.3 M-47.75%
2022-12-31$0.16 B-65.33%
2021-12-31$0.47 B-27.01%
2020-12-31$0.65 B-10.3%
2019-12-31$0.72 B3.97%
2018-12-31$0.69 B177.32%
2017-12-31$0.25 B9.38%
2016-12-31$0.23 B2.03%
2015-12-31$0.22 B-3.2%
2014-12-31$0.23 B323.99%
2013-12-31$55.1 M-29.15%
2012-12-31$77.77 M-30.8%
2011-12-31$0.11 B39.78%
2010-12-31$80.4 M-41.76%
2009-12-31$0.13 B-24.06%
2008-12-31$0.18 B26.12%
2007-12-31$0.14 B-51.74%
2006-12-31$0.29 B-29.72%
2005-12-31$0.42 B4.23%
2004-12-31$0.40 B15.98%
2003-12-31$0.35 B74.57%
2002-12-31$0.20 B14.87%
2001-12-31$0.17 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
$80.52 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
$80.87 M-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$61.28 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$77.63 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$91.08 B 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$78.28 B 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$13.85 B 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA